1.
Thomas Hartung. Artificial intelligence as the new frontier in chemical risk assessment. Frontiers in Artificial Intelligence. 2023;6:1269932. doi:10.3389/frai.2023.1269932
Thomas Hartung
1.
Sebastian Schmeisser, Andrea Miccoli, Martin von Bergen, et al. New approach methodologies in human regulatory toxicology – Not if, but how and when! Environment International. 2023;178:108082. doi:10.1016/j.envint.2023.108082
1.
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. The Journal of Infectious Diseases. 2023:jiad334. doi:10.1093/infdis/jiad334
1.
Paula Barreras, David Pamies, Thomas Hartung, Carlos A. Pardo. Human brain microphysiological systems in the study of neuroinfectious disorders. Experimental Neurology. 2023;365:114409. doi:10.1016/j.expneurol.2023.114409
1.
Camilla Svendsen, Paul Whaley, Gunn E. Vist, et al. Protocol for designing INVITES-IN, a tool for assessing the internal validity of in vitro studies. Evidence-Based Toxicology. 2023;1(1):2232415. doi:10.1080/2833373X.2023.2232415
1.
Costanza Rovida, Francois Busquet, Marcel Leist, Thomas Hartung. REACH out-numbered! The future of REACH and animal numbers. ALTEX - Alternatives to Animal Experimentation. 2023;40(3):367-388. doi:10.14573/altex.2307121
1.
Jean Knight, Thomas Hartung, Costanza Rovida. 4.2 million and counting… The animal toll for REACH systemic toxicity studies. ALTEX - Alternatives to animal experimentation. 2023;40(3):389-407. doi:10.14573/altex.2303201
1.
Gro H. Mathisen, Gunn E. Vist, Paul Whaley, et al. Protocol: Testing the Performance of INVITES-IN, A Tool for Assessing the Internal Validity of In Vitro Studies. Evidence-Based Toxicology. 2023;1(1):2293289. doi:10.1080/2833373X.2023.2293289
1.
Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
1.
David Pamies, Marcel Leist, Sandra Coecke, et al. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0). Alternatives to Animal Experimentation. 2022;39(1):30-70. doi:10.14573/altex.2111011